EndPoints notes that the Most Favored Nation Executive Order has led some large pharmaceutical firms to make two changes: (i) start charging Europeans the same price as the US, and (ii) start selling more products direct to consumer (a.k.a. ‘pharm to table‘) AbbVie, Novartis and Boehringer Ingelheim each joined their peers in making price-related concessions…
Successful mergers don’t just consolidate services. They unify people around a shared mission to serve their patients. If we want to see lasting success in healthcare M&A, it’s time to stop leading with checklists and start leading with people. The post Why Healthcare Mergers Fail and How to Prevent a Costly Collapse appeared first on…
The Bipartisan Policy Center’s Youth Mental Health and Substance Use Task Force recently released a report focused on redesigning the healthcare system to support youth mental health. Here are five key findings. The post 5 Ways the Healthcare Industry Should Improve Youth Mental Health, Per BPC’s Task Force appeared first on MedCity News.
June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health and HCA Healthcare welcomed new executives, and Ascension and Optum Health announced that their CEOs are departing. There were also layoffs at organizations including Providence, UCSF Health and Vanderbilt University Medical Center. The post Healthcare…
Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…
Perhaps this is what President Trump is exploring. Reuters reports: Drugmakers have been warned that the Trump Administration is considering linking U.S. medicine prices to lower amounts paid by other developed countries, according to two company sources who called the option the pharmaceutical industry’s top concern.Both sources, who were not authorized to speak publicly, said…
Advances in flow cytometry could enable researchers to uncover valuable insights about food allergies without allergen exposure. The post Attacking Food Allergies: How Technology can Ease the Path to New Treatments Without the Pain appeared first on MedCity News.
Medicare beneficiaries will have 32 Medicare Advantage plans with prescription drug coverage available to choose from, on average, in 2026.
Fay’s $50 million Series B round was led by Goldman Sachs. In total, the company has raised $75 million. The post Fay Raises $50M to Expand Access to Nutrition Counseling Services appeared first on MedCity News.
How race, ethnicity, and nationality have been defined and measured has important implications for health disparities, affecting who can access health, social, and economic resources. While narrow and inconsistent race and ethnicity categories have obscured inequities and limited the ability to address the diverse needs of different populations, data on race and ethnicity have also…